San Diego, CA, United States of America

Andrea Fin

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrea Fin. Retrieved from https://idiyas.com/inventor/andrea-fin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrea Fin: Innovator in Cyclic Dinucleotide Compounds

Introduction

Andrea Fin is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cyclic dinucleotide compounds. Her work focuses on creating innovative solutions for treating various diseases and disorders.

Latest Patents

Andrea Fin holds a patent for "Cyclic dinucleotide compounds as STING agonists." This patent discloses cyclic dinucleotides that are useful as STING agonists, along with pharmaceutical compositions and vaccines that incorporate these compounds. The methods outlined in her patent aim to treat diseases and disorders effectively using these innovative cyclic dinucleotides.

Career Highlights

Andrea Fin is affiliated with the University of California, where she continues her research and development efforts. Her work has garnered attention for its potential impact on therapeutic applications and vaccine development.

Collaborations

Andrea has collaborated with notable colleagues, including Yitzhak Tor and Yao Li, to advance her research and explore new avenues in the field of cyclic dinucleotide compounds.

Conclusion

Andrea Fin's contributions to the field of pharmaceutical sciences through her innovative patent work exemplify her dedication to advancing medical treatments. Her research continues to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…